CRVL · Corvel Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $235.63M | $239.64M | $234.71M | $227.97M | $224.38M | $211.72M | $202.30M | $195.52M | $190.25M |
| Cost of Revenue | - | $180.71M | $181.47M | $177.95M | $175.12M | $173.63M | $163.57M | $160.14M | $151.27M | $148.38M |
| Gross Profit | - | $54.92M | $58.18M | $56.76M | $52.86M | $50.75M | $48.16M | $42.16M | $44.25M | $41.88M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | $22.68M | $22.28M | $21.48M | $22.06M | $22.08M | $20.12M | $19.80M | $19.54M | $16.45M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | $8.07M | $7.84M | $7.59M | - | - | $6.73M | - | - | $6.36M |
| Operating Income | - | $32.23M | $35.90M | $35.28M | $30.80M | $28.67M | $28.04M | $22.36M | $24.71M | $25.43M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | $8.06M | $7.99M | $8.05M | $7.03M | $5.27M | $6.46M | $5.27M | $4.82M | $5.62M |
| Net Income | - | $24.17M | $27.91M | $27.23M | $23.77M | $23.40M | $21.58M | $17.09M | $19.90M | $19.80M |
| EPS - Basic | - | $0.47 | $0.54 | $0.53 | $0.46 | $0.46 | $0.42 | $0.33 | $0.39 | $0.39 |
| EPS - Diluted | - | $0.47 | $0.54 | $0.52 | $0.46 | $0.45 | $0.42 | $0.33 | $0.38 | $0.38 |
Balance Sheet
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $233.07M | $230.03M | $207.45M | $202.03M | $162.94M | $138.35M | $131.91M | $106.99M | $91.75M | $86.59M |
| Accounts Receivable | $101.31M | $102.10M | $104.92M | $101.97M | $106.18M | $102.39M | $97.75M | $92.66M | $86.94M | $84.18M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $24.32M | $25.87M | $19.14M | $21.18M | $14.59M | $13.70M | $12.37M | $14.93M | $15.15M | $14.65M |
| Current Assets | $462.30M | $463.92M | $434.27M | $421.62M | $383.16M | $363.33M | $333.26M | $294.39M | $281.88M | $267.95M |
| Total Assets | $642.99M | $644.78M | $611.68M | $597.45M | $538.78M | $518.55M | $486.17M | $445.00M | $434.12M | $417.57M |
| Current Liabilities | $228.07M | $250.45M | $230.33M | $235.22M | $216.74M | $212.86M | $200.59M | $188.39M | $186.50M | $187.73M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $248.75M | $269.06M | $248.90M | $254.92M | $237.93M | $235.78M | $222.30M | $211.47M | $211.55M | $210.59M |
| Stockholders' Equity | $394.23M | $375.72M | $362.78M | $342.53M | $300.85M | $282.77M | $263.87M | $233.53M | $222.57M | $206.98M |
| Retained Earnings | $1.01B | $982.40M | $958.23M | $930.32M | $876.67M | $852.89M | $829.50M | $788.47M | $771.37M | $751.47M |
Cash Flow
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | $55.01M | - | - | $40.44M | - | - | $36.63M |
| Investing Cash Flow | - | - | - | ($15.46M) | - | - | ($7.67M) | - | - | ($5.05M) |
| Financing Cash Flow | - | - | - | ($8.11M) | - | - | ($6.42M) | - | - | ($16.31M) |
| CapEx | - | - | - | $15.46M | - | - | $7.67M | - | - | $5.05M |
| Free Cash Flow | - | - | - | $39.55M | - | - | $32.77M | - | - | $31.58M |
Ratios
| Metric | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 23.3% | 24.3% | 24.2% | 23.2% | 22.6% | 22.7% | 20.8% | 22.6% | 22.0% |
| Operating margin | - | 13.7% | 15.0% | 15.0% | 13.5% | 12.8% | 13.2% | 11.1% | 12.6% | 13.4% |
| EBITDA margin | - | 17.1% | 18.3% | 18.3% | - | - | 16.4% | - | - | 16.7% |
| Net margin | - | 10.3% | 11.6% | 11.6% | 10.4% | 10.4% | 10.2% | 8.5% | 10.2% | 10.4% |
| Free cash flow margin | - | - | - | 16.8% | - | - | 15.5% | - | - | 16.6% |
| FCF / Net income | - | - | - | 1.45 | - | - | 1.52 | - | - | 1.59 |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | 9.6% | 9.3% | 9.2% | 9.7% | 9.8% | 9.5% | 9.8% | 10.0% | 8.6% |
| Effective tax rate | - | 25.0% | 22.3% | 22.8% | 22.8% | 18.4% | 23.0% | 23.6% | 19.5% | 22.1% |
| Return on assets | - | 3.7% | 4.6% | 4.6% | 4.4% | 4.5% | 4.4% | 3.8% | 4.6% | 4.7% |
| Return on equity | - | 6.4% | 7.7% | 8.0% | 7.9% | 8.3% | 8.2% | 7.3% | 8.9% | 9.6% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.03 | 1.85 | 1.89 | 1.79 | 1.77 | 1.71 | 1.66 | 1.56 | 1.51 | 1.43 |
| Quick ratio | 2.03 | 1.85 | 1.89 | 1.79 | 1.77 | 1.71 | 1.66 | 1.56 | 1.51 | 1.43 |
| Cash ratio | 1.02 | 0.92 | 0.90 | 0.86 | 0.75 | 0.65 | 0.66 | 0.57 | 0.49 | 0.46 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.63 | 1.72 | 1.69 | 1.74 | 1.79 | 1.83 | 1.84 | 1.91 | 1.95 | 2.02 |
| Liabilities / Assets | 0.39 | 0.42 | 0.41 | 0.43 | 0.44 | 0.45 | 0.46 | 0.48 | 0.49 | 0.50 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.37 | 0.39 | 0.39 | 0.42 | 0.43 | 0.44 | 0.45 | 0.45 | 0.46 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | 158d | 160d | 159d | 170d | 167d | 169d | 167d | 162d | 161d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | 52d | 39d | 43d | 30d | 29d | 28d | 34d | 37d | 36d |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | 144.0x | 143.4x | 197.7x | 241.9x | 242.1x | 203.4x | 249.7x | 171.0x | 169.7x |
| P / B | - | 9.3x | 11.0x | 15.6x | 19.2x | 6.7x | 5.6x | 6.1x | 5.1x | 5.4x |
| P / S | - | 14.8x | 16.7x | 22.7x | 25.4x | 8.4x | 6.9x | 7.1x | 5.8x | 5.9x |
| EV / EBITDA | - | 80.9x | 86.8x | 119.7x | - | - | 38.4x | - | - | 32.5x |
| Growth | ||||||||||
| Revenue growth (YoY) | - | 3.4% | 6.8% | 10.9% | 12.7% | 14.8% | 11.3% | 12.8% | 10.2% | 7.9% |
| Revenue CAGR (3y) | - | 9.5% | 10.5% | 10.0% | 17.2% | 18.2% | 17.8% | 11.0% | 10.0% | 8.2% |
| Revenue CAGR (5y) | - | 9.7% | 10.3% | 9.3% | 10.1% | 8.7% | 9.0% | - | - | - |
| Gross profit growth (YoY) | - | 3.9% | 14.6% | 17.9% | 25.4% | 14.7% | 15.0% | 4.5% | 22.6% | 5.0% |
| Operating income growth (YoY) | - | 4.6% | 25.2% | 25.9% | 37.7% | 16.0% | 10.3% | 0.7% | 33.3% | 20.0% |
| Net income growth (YoY) | - | 1.7% | 19.3% | 26.2% | 39.1% | 17.6% | 8.9% | 1.5% | 35.8% | 18.7% |
| EPS growth (YoY) | - | 2.2% | 20.0% | 24.8% | 39.4% | 17.4% | 9.6% | -65.6% | -53.8% | -59.6% |
| EPS CAGR (3y) | - | -21.2% | -13.3% | -17.9% | -10.0% | -11.5% | -3.2% | -12.9% | -17.8% | -18.8% |
| EPS CAGR (5y) | - | -1.2% | -4.8% | -6.0% | -3.2% | -7.7% | -7.6% | -8.0% | -2.7% | -3.7% |
| FCF growth (YoY) | - | - | - | 20.7% | - | - | 3.8% | - | - | 45.9% |
| FCF CAGR (5y) | - | - | - | 16.6% | - | - | 12.2% | - | - | 14.5% |
| Book value growth (YoY) | 15.1% | 24.9% | 28.3% | 29.8% | 28.8% | 27.0% | 27.5% | 19.9% | 12.5% | 0.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-03-31.
Product / service
$958.53M totalPatient Management Services$596.70M · 62.3%
Network Solutions Services$361.82M · 37.7%
Peer comparison
Same SIC group: Insurance Agents, Brokers & Service
Comparing CORVEL CORP against the 5 most active filers in the same SIC group.